Cynata Therapeutics posts FY2026 after-tax loss of A$9.1 million
Cynata Therapeutics reported a FY2026 loss from ordinary activities after tax of A$9.1 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.